Alzheimer disease: Insulin resistance and AD--extending the translational path. (Q53329640)

13 May 2018

title

Alzheimer disease: Insulin resistance and AD--extending the translational path. (English)

1 reference

13 May 2018

1 reference

Suzanne Craft

1

1 reference

13 May 2018

language of work or name

English

0 references

publication date

19 June 2012

1 reference

13 May 2018

published in

Nature Reviews Neurology

1 reference

13 May 2018

volume

8

1 reference

13 May 2018

page(s)

360-362

1 reference

13 May 2018

issue

7

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/nrneurol.2012.112

exact match

0 references

cites work

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

The effect of glucagon-like peptide 1 on cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.112

10.1038/NRNEUROL.2012.112

31 March 2020

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

22710630

1 reference

13 May 2018